Showing results (11-20 of 147) with videos related to
Sort By:
Pageof 15
Pharmacoeconomics|July 16, 2010
The value of value of information: best informing research design and prioritization using current methodsSimon Eckermann, Jon Karnon, Andrew R WillanMedical Decision Making : an International Journal of the Society for Medical Decision Making|March 22, 2008
Health technology assessment in the cost-disutility planeSimon Eckermann, Andrew Briggs, Andrew R WillanJournal of Clinical Epidemiology|January 31, 2009
Indirect comparison: relative risk fallacies and odds solutionSimon Eckermann, Michael Coory, Andrew R WillanPharmacoeconomics|December 21, 2010
Consistently estimating absolute risk difference when translating evidence to jurisdictions of interestSimon Eckermann, Michael Coory, Andrew R WillanClinical Trials (London, England)|November 26, 2008
Optimal sample size determinations from an industry perspective based on the expected value of informationAndrew R WillanExpert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Statistical analysis of cost-effectiveness data from randomized clinical trialsAndrew R WillanClinical Trials (London, England)|August 24, 2007
Clinical decision making and the expected value of informationAndrew R WillanEuropean Journal of Gastroenterology & Hepatology|May 29, 2004
Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trialAndrew R WillanPharmacoeconomics|October 13, 2011
Sample size determination for cost-effectiveness trialsAndrew R WillanPageof 15